Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Galderma, Switzerland's discreet Botox empire

The dermatology company's market capitalization has doubled since its initial public offering in 2024. Despite recurring scandals, botulinum toxin injections are expected to rake in $13 billion this year.

Galderma, Switzerland's discreet Botox empire

We haven't written up this one. Le Monde English has the full story — the link below goes straight to it.

Read the original at lemonde.fr →

More in Health & Medicine

More from Friday 2 October →